Dr. Lisa Maragakis

Lisa Maragakis, M.D., M.P.H., FSHEA, FIDSA is a professor of medicine and epidemiology at Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. Dr. Maragakis is the Senior Director of Infection Prevention, for The Johns Hopkins Health System and the Hospital Epidemiologist for The Johns Hopkins Hospital. In these roles, she is responsible for the conceptualization, planning, implementation, and development of the Johns Hopkins Health System's infection control and prevention program. Her research interests are the epidemiology, prevention and control of healthcare-acquired infections and antimicrobial-resistant gram-negative bacilli. Dr. Maragakis serves as the Executive Director of the Johns Hopkins Hospital Biocontainment Unit and as Incident Commander for the Johns Hopkins Medicine COVID-19 response. She also serves as the IDSA Co-Chair for the 2022 Update of the Compendium of Strategies to Prevent Healthcare-Associated Infections, and as Co-Chair of the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC).

Dr. Maragakis is rated as an Advanced provider by MediFind in the treatment of Ebola Virus Disease. Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Ebola Virus Disease, Severe Acute Respiratory Syndrome (SARS), Viral Hemorrhagic Fever, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 107 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Ebola Virus Disease.